{"category":{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","tagline":null,"description":null,"synonyms":[],"target_queries":[],"added_via":"pr","added_at":"2026-09-03T06:00:13.937Z","updated_at":"2026-09-03T06:00:13.937Z","example":false,"profile_url":"/industries/synthetic-biology","is_stub":true,"member_count":32,"member_counts":{"accelerator":3,"company":29}},"members":[{"listing_type":"company","name":"TareBio","slug":"tarebio","tagline":"Vaccines for any cancer or infection in weeks.","description":"Our platform develops personalized or population-level vaccines for any disease in weeks by changing only one input: the immune imprint. Instead of trying to predict which antigens might work, we read out immune cells already fighting the disease in the body and reverse-engineer antigens that activate them. We've already run our platform end-to-end and created a vaccine that cured cancer in mice.\n\nTareBio is a Y Combinator company (Summer 2026). YC-listed status: Active.","url":"https://tarebio.com/","is_stealth":false,"normalized_domain":"tarebio.com","normalized_url_key":"tarebio.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/9e770bbea41518001119968d389d0d3e35ce7abe.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/tarebio","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://tarebio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://tarebio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Drug Discovery and Delivery","Vaccines","Synthetic Biology","Biotechnology"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T08:32:26.489Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2026","Vaccines","Synthetic Biology","Biotechnology"],"one_liner_for_search":"TareBio — Vaccines for any cancer or infection in weeks. (Y Combinator Summer 2026)","canonical_facts":["Y Combinator batch: Summer 2026","YC company status: Active","Team size (per YC directory): 1","YC industry: Healthcare","YC subindustry: Healthcare / Drug Discovery and Delivery","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T08:32:26.489Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"},{"kind":"industry","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/industries/drug-discovery-and-delivery"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"},{"kind":"industry","slug":"vaccines","name":"Vaccines","note":null,"profile_url":"/industries/vaccines"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T08:32:26.489Z","updated_at":"2026-09-03T08:32:26.489Z"}},{"listing_type":"company","name":"Molagri","slug":"molagri","tagline":"Resistance free pesticides.","description":"Molagri develops safer, more effective pesticides for agriculture.\n\nWe design biopesticides that hit a precise molecular target unique to pest insects, knocking out pests while sparing pollinators, beneficial insects, and the wider ecosystem. By modeling how pests are likely to evolve, we stay a step ahead of resistance, keeping our products effective against the pests of today and tomorrow. The higher efficacy and biobased production will also contribute to emissions reductions in both manufacturing and field use.\n\nOur founders are PhD lab mates from the University of Toronto who have worked together for six years and published in Nature Communications and Nature Microbiology.\n\nMolagri is a Y Combinator company (Summer 2026). YC-listed status: Active.","url":"https://molagri.com/","is_stealth":false,"normalized_domain":"molagri.com","normalized_url_key":"molagri.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/71eba8e2b8b0a262e4c76ef41e5ab46b59552e6d.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/molagri","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://molagri.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://molagri.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Industrials","Agriculture","Synthetic Biology","Biotech","Sustainability","Climate"],"stage":null,"founded_year":null,"location":"Toronto, ON, Canada","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T08:32:14.494Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2026","Synthetic Biology","Biotech","Sustainability","Climate","Agriculture"],"one_liner_for_search":"Molagri — Resistance free pesticides. (Y Combinator Summer 2026)","canonical_facts":["Y Combinator batch: Summer 2026","YC company status: Active","Team size (per YC directory): 4","YC industry: Industrials","YC subindustry: Industrials / Agriculture","Regions (per YC): Canada, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T08:32:14.494Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"agriculture","name":"Agriculture","note":null,"profile_url":"/industries/agriculture"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"climate","name":"Climate","note":null,"profile_url":"/industries/climate"},{"kind":"industry","slug":"industrials","name":"Industrials","note":null,"profile_url":"/industries/industrials"},{"kind":"industry","slug":"sustainability","name":"Sustainability","note":null,"profile_url":"/industries/sustainability"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T08:32:14.494Z","updated_at":"2026-09-03T08:32:14.494Z"}},{"listing_type":"company","name":"1849 bio","slug":"1849-bio","tagline":"Engineering microbes for miners to unlock billions in trapped metal","description":"1849 bio designs microbes enabling cheap metal extraction allowing miners to unlock value from low quality copper and gold ores. Surprisingly, the mining industry is one of the largest scale users of biotech in the world with biomining processes accounting for ~1% of global copper production. Biomining is ultra-low cost, running around ~$1/ton of ore vs ~$7/ton for conventional processes. \n\nUnfortunately, while biomining is cheap, it can’t be applied to over 80% of copper ores, leaving vast resources without profitable extraction methods. An estimated ~$800B of copper sit today in waste materials and stockpiles with negative unit economics.\n\nWhile a great deal of effort has been spent on optimizing microbial metal extraction processes, very little effort has been spent on optimizing the microbes themselves. \n\nTo change that, we’re creating new biotech tools and platforms applied directly to the types of biology most relevant to miners. This enables us to develop new microbes and tackle some of the most difficult problems in biomining, unlocking billions in value from unprofitable resources while being more environmentally friendly than conventional processes.\n\nWe’re world class microbial engineers. We met while doing our PhDs in synthetic biology, where we spent our time applying and developing the most advanced bioengineering technologies to engineer living cells.\n\n1849 bio is a Y Combinator company (Summer 2024). YC-listed status: Active.","url":"https://1849.bio/","is_stealth":false,"normalized_domain":"1849.bio","normalized_url_key":"1849.bio","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/6a17250c337f8e98ac79079d08da2abffb3b3b6b.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/1849-bio","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://1849.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://1849.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Industrials","Hard Tech","Synthetic Biology","Biotech","Climate","Mining"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:50:14.968Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2024","Hard Tech","Synthetic Biology","Biotech","Climate","Mining"],"one_liner_for_search":"1849 bio — Engineering microbes for miners to unlock billions in trapped metal (Y Combinator Summer 2024)","canonical_facts":["Y Combinator batch: Summer 2024","YC company status: Active","Team size (per YC directory): 3","YC industry: Industrials","YC subindustry: Industrials","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:50:14.968Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"climate","name":"Climate","note":null,"profile_url":"/industries/climate"},{"kind":"industry","slug":"hard-tech","name":"Hard Tech","note":null,"profile_url":"/industries/hard-tech"},{"kind":"industry","slug":"industrials","name":"Industrials","note":null,"profile_url":"/industries/industrials"},{"kind":"industry","slug":"mining","name":"Mining","note":null,"profile_url":"/industries/mining"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:50:14.968Z","updated_at":"2026-09-03T07:50:14.968Z"}},{"listing_type":"company","name":"Kopra Bio","slug":"kopra-bio","tagline":"Genetically engineered viruses that teach your immune system to kill…","description":"Kopra Bio makes genetically engineered viruses that teach your immune system to kill cancer using tech we developed at UCSF. We’re making the next Keytruda ($25B/yr cancer drug blockbuster) starting with the most aggressive form of brain cancer, glioblastoma. In the most challenging brain cancer model, we improve survival from 0% with the current FDA approved treatment to 90% with our treatment.\n\nKopra Bio is a Y Combinator company (Summer 2024). YC-listed status: Active.","url":"https://www.kopra.bio/","is_stealth":false,"normalized_domain":"kopra.bio","normalized_url_key":"kopra.bio","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/acdb0c2a3124d9e5717a63d0231af9b6f7447919.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/kopra-bio","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.kopra.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.kopra.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Gene Therapy","Synthetic Biology","Biotech","Oncology"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:49:28.291Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2024","Gene Therapy","Synthetic Biology","Biotech","Therapeutics","Oncology"],"one_liner_for_search":"Kopra Bio — Genetically engineered viruses that teach your immune system to kill… (Y Combinator Summer 2024)","canonical_facts":["Y Combinator batch: Summer 2024","YC company status: Active","Team size (per YC directory): 2","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Former names: GlioTx","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:49:28.291Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/industries/gene-therapy"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:49:28.291Z","updated_at":"2026-09-03T07:49:28.291Z"}},{"listing_type":"company","name":"AminoAnalytica","slug":"aminoanalytica","tagline":"The AI scientist for always-on biodefense","description":"We design point-of-care diagnostics for emerging biological threats - in days, not 12+ months.\n\nAminoAnalytica is a Y Combinator company (Summer 2024). YC-listed status: Active.","url":"https://www.aminoanalytica.com/","is_stealth":false,"normalized_domain":"aminoanalytica.com","normalized_url_key":"aminoanalytica.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/f7d5463656052d09bd1bc697531992af867d844c.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/aminoanalytica","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.aminoanalytica.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.aminoanalytica.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Diagnostics","Nanosensors","Synthetic Biology","Biotech"],"stage":null,"founded_year":null,"location":"London, England, United Kingdom","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:49:10.734Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2024","Nanosensors","Synthetic Biology","Biotech","Diagnostics"],"one_liner_for_search":"AminoAnalytica — The AI scientist for always-on biodefense (Y Combinator Summer 2024)","canonical_facts":["Y Combinator batch: Summer 2024","YC company status: Active","Team size (per YC directory): 3","YC industry: Healthcare","YC subindustry: Healthcare / Diagnostics","Regions (per YC): United Kingdom, Europe, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:49:10.734Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"diagnostics","name":"Diagnostics","note":null,"profile_url":"/industries/diagnostics"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"nanosensors","name":"Nanosensors","note":null,"profile_url":"/industries/nanosensors"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:49:10.734Z","updated_at":"2026-09-03T07:49:10.734Z"}},{"listing_type":"company","name":"ParcelBio","slug":"parcelbio","tagline":"Elevated mRNA for transformative medicines.","description":"ParcelBio is engineering a new class of mRNA medicines designed to deliver unprecedented potency and durability. Its proprietary APEXm™ platform uses novel RNA domains to enhance protein expression and extend activity, enabling therapies that reach the thresholds required for meaningful, and potentially curative, clinical outcomes. The company is advancing programs in autoimmune disease, oncology, and encoded protein therapeutics.\n\nParcelBio is a Y Combinator company (Winter 2024). YC-listed status: Active.","url":"https://parcelbio.com/","is_stealth":false,"normalized_domain":"parcelbio.com","normalized_url_key":"parcelbio.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/74f762bd0f8856c1dbe4d716afa6585e44f03870.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/parcelbio","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://parcelbio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://parcelbio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Gene Therapy","Synthetic Biology","Biotech","Drug discovery"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:46:05.163Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2024","Gene Therapy","Synthetic Biology","Biotech","Therapeutics","Drug discovery"],"one_liner_for_search":"ParcelBio — Elevated mRNA for transformative medicines. (Y Combinator Winter 2024)","canonical_facts":["Y Combinator batch: Winter 2024","YC company status: Active","Team size (per YC directory): 6","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Former names: Parcel Therapuetics, Parcel Therapeutics","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:46:05.163Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"drug-discovery","name":"Drug discovery","note":null,"profile_url":"/industries/drug-discovery"},{"kind":"industry","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/industries/gene-therapy"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:46:05.163Z","updated_at":"2026-09-03T07:46:05.163Z"}},{"listing_type":"company","name":"Granza Bio","slug":"granza-bio","tagline":"Building programmable therapeutics for the immune system","description":"Granza Bio is developing programmable therapeutics for the immune system. Our platform is built on the foundational discovery of immune “superkiller” attack particles — the natural ammunition used by cytotoxic immune cells to deliver potent, localized killing. By re-arming exhausted immune cells with newly programmed ammunition, Granza restores and enhances immune function. This approach enables a new class of treatments with the potential to transform diseases ranging from cancer to autoimmunity.\n\nGranza Bio is a Y Combinator company (Winter 2024). YC-listed status: Active.","url":"https://www.granzabio.com/","is_stealth":false,"normalized_domain":"granzabio.com","normalized_url_key":"granzabio.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/e4fe5f43800f16c0ca16303f58b955037e3f2bc1.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/granza-bio","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.granzabio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.granzabio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Synthetic Biology","Biotech","Oncology"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:45:07.063Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2024","Synthetic Biology","Biotech","Healthcare","Therapeutics","Oncology"],"one_liner_for_search":"Granza Bio — Building programmable therapeutics for the immune system (Y Combinator Winter 2024)","canonical_facts":["Y Combinator batch: Winter 2024","YC company status: Active","Team size (per YC directory): 8","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Former names: Zyme Therapeutics","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:45:07.063Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:45:07.063Z","updated_at":"2026-09-03T07:45:07.063Z"}},{"listing_type":"company","name":"Ligo Biosciences","slug":"ligo-biosciences","tagline":"Enzyme design models.","description":"We are building the next generation of deep-learning models for enzyme design to slash the cost of chemical manufacturing. The $6 trillion chemical industry is flawed: It produces 20% of industrial greenhouse gases, and is responsible for 15% of global energy usage. \n\nEnzymes offer a far more sustainable alternative to chemical synthesis and have already revolutionised how a select few chemicals are produced. The problem is each enzyme takes years of trial and error to develop. Our enzyme models learn the principles of catalysis, allowing us to design enzymes for each reaction, in days not years.\n\nLigo Biosciences is a Y Combinator company (Summer 2024). YC-listed status: Active.","url":"https://www.ligo.bio/","is_stealth":false,"normalized_domain":"ligo.bio","normalized_url_key":"ligo.bio","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/bd381079ddb420940e9b57512009e6b5bc73e27a.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/ligo-biosciences","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.ligo.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.ligo.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Industrial Bio","Artificial Intelligence","Deep Learning","Synthetic Biology","Biotech","Climate"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:43:02.970Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2024","Artificial Intelligence","Deep Learning","Synthetic Biology","Biotech","Climate"],"one_liner_for_search":"Ligo Biosciences — Enzyme design models. (Y Combinator Summer 2024)","canonical_facts":["Y Combinator batch: Summer 2024","YC company status: Active","Team size (per YC directory): 4","YC industry: Healthcare","YC subindustry: Healthcare / Industrial Bio","Former names: Ligo, Ligo Bio","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:43:02.970Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"artificial-intelligence","name":"Artificial Intelligence","note":null,"profile_url":"/industries/artificial-intelligence"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"climate","name":"Climate","note":null,"profile_url":"/industries/climate"},{"kind":"industry","slug":"deep-learning","name":"Deep Learning","note":null,"profile_url":"/industries/deep-learning"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"industrial-bio","name":"Industrial Bio","note":null,"profile_url":"/industries/industrial-bio"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:43:02.970Z","updated_at":"2026-09-03T07:43:02.970Z"}},{"listing_type":"company","name":"ACX","slug":"acx","tagline":"Next-generation biocides for sustainable agriculture at scale","description":"ACX is developing a new standard for precision agriculture technologies by providing sustainable, eco-friendly alternatives to chemical pesticides. Our mission is to transform agriculture through sustainable biological crop protection that increases yields while safeguarding the environment, farmers, and consumers.\n\nACX is a Y Combinator company (Summer 2024). YC-listed status: Active.","url":"https://www.acxtherapeutics.com/","is_stealth":false,"normalized_domain":"acxtherapeutics.com","normalized_url_key":"acxtherapeutics.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/9bb37e7a5bced1e654bfc08df7f21868e28bd64c.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/acx","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.acxtherapeutics.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.acxtherapeutics.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Industrial Bio","Synthetic Biology","Biotech","Agriculture","Drug discovery"],"stage":null,"founded_year":null,"location":"New York City, NY, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:42:23.582Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2024","Synthetic Biology","Biotech","Healthcare","Agriculture","Drug discovery"],"one_liner_for_search":"ACX — Next-generation biocides for sustainable agriculture at scale (Y Combinator Summer 2024)","canonical_facts":["Y Combinator batch: Summer 2024","YC company status: Active","Team size (per YC directory): 4","YC industry: Healthcare","YC subindustry: Healthcare / Industrial Bio","Former names: AcX Therapeutics, AcX","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:42:23.582Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"agriculture","name":"Agriculture","note":null,"profile_url":"/industries/agriculture"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"drug-discovery","name":"Drug discovery","note":null,"profile_url":"/industries/drug-discovery"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"industrial-bio","name":"Industrial Bio","note":null,"profile_url":"/industries/industrial-bio"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:42:23.582Z","updated_at":"2026-09-03T07:42:23.582Z"}},{"listing_type":"company","name":"SynsoryBio","slug":"synsorybio","tagline":"\"If-then\" conditional logic for protein drugs","description":"SynsoryBio is creating next generation, protein therapeutics that sense where they are in the body and only activate at diseased tissue. This technology platform has the potential to expand the therapeutic window of highly potent drugs and apply to many diseases such as cancer and autoimmune disorders.\n\nSynsoryBio is a Y Combinator company (Winter 2024). YC-listed status: Active.","url":"https://www.synsorybio.com/","is_stealth":false,"normalized_domain":"synsorybio.com","normalized_url_key":"synsorybio.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/e2b7538a15335c79e864ff7431e761c3feca0797.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/synsorybio","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.synsorybio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.synsorybio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Synthetic Biology","Biotech","Oncology"],"stage":null,"founded_year":null,"location":"Boston, MA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:39:17.707Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2024","Synthetic Biology","Biotech","Therapeutics","Oncology"],"one_liner_for_search":"SynsoryBio — \"If-then\" conditional logic for protein drugs (Y Combinator Winter 2024)","canonical_facts":["Y Combinator batch: Winter 2024","YC company status: Active","Team size (per YC directory): 2","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:39:17.707Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:39:17.707Z","updated_at":"2026-09-03T07:39:17.707Z"}},{"listing_type":"company","name":"Ohmic Biosciences","slug":"ohmic-biosciences","tagline":"Genetically engineering plants for disease resistance.","description":"Pests and pathogens cost the world hundreds of billions of dollars every year. Existing technologies like agrochemicals are no longer working. Ohmic Biosciences uses protein engineering to design resistance genes for crops that are robust to pathogen evolution.\n\nOhmic Biosciences is a Y Combinator company (Summer 2023). YC-listed status: Active.","url":"https://ohmicbiosciences.com/","is_stealth":false,"normalized_domain":"ohmicbiosciences.com","normalized_url_key":"ohmicbiosciences.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/5b68cb6a90af9c37176d63232ab7f6372925388d.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/ohmic-biosciences","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://ohmicbiosciences.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://ohmicbiosciences.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Industrials","Agriculture","Synthetic Biology","Biotech","Climate","Genetic Engineering"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:30:07.361Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2023","Synthetic Biology","Biotech","Climate","Agriculture","Genetic Engineering"],"one_liner_for_search":"Ohmic Biosciences — Genetically engineering plants for disease resistance. (Y Combinator Summer 2023)","canonical_facts":["Y Combinator batch: Summer 2023","YC company status: Active","Team size (per YC directory): 2","YC industry: Industrials","YC subindustry: Industrials / Agriculture","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:30:07.361Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"agriculture","name":"Agriculture","note":null,"profile_url":"/industries/agriculture"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"climate","name":"Climate","note":null,"profile_url":"/industries/climate"},{"kind":"industry","slug":"genetic-engineering","name":"Genetic Engineering","note":null,"profile_url":"/industries/genetic-engineering"},{"kind":"industry","slug":"industrials","name":"Industrials","note":null,"profile_url":"/industries/industrials"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:30:07.361Z","updated_at":"2026-09-03T07:30:07.361Z"}},{"listing_type":"company","name":"Pando Bioscience","slug":"pando-bioscience","tagline":"Gen-AI Designed Enzymes for Pharmaceutical Innovation","description":"Pando is an AI-driven synthetic biology company revolutionizing enzyme engineering for the pharmaceutical industry. Our ultra-high-throughput screening platform screens 1000-fold more enzymes 75% faster and 80% cheaper than traditional methods. This empowers our generative AI to efficiently optimize enzymes across multiple properties, delivering high-performing, tailored enzymes that reduce costs and enhance efficiency.\n\nPando Bioscience is a Y Combinator company (Winter 2023). YC-listed status: Active.","url":"https://www.pando.bio/","is_stealth":false,"normalized_domain":"pando.bio","normalized_url_key":"pando.bio","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/fcb2bf6569db61c3592824679114d563e4d1438c.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/pando-bioscience","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.pando.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.pando.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Industrial Bio","Generative AI","Synthetic Biology","Biotech","Diagnostics"],"stage":null,"founded_year":null,"location":"Boston, MA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:29:16.025Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2023","Generative AI","Synthetic Biology","Biotech","Diagnostics"],"one_liner_for_search":"Pando Bioscience — Gen-AI Designed Enzymes for Pharmaceutical Innovation (Y Combinator Winter 2023)","canonical_facts":["Y Combinator batch: Winter 2023","YC company status: Active","Team size (per YC directory): 5","YC industry: Healthcare","YC subindustry: Healthcare / Industrial Bio","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:29:16.025Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"diagnostics","name":"Diagnostics","note":null,"profile_url":"/industries/diagnostics"},{"kind":"industry","slug":"generative-ai","name":"Generative AI","note":null,"profile_url":"/industries/generative-ai"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"industrial-bio","name":"Industrial Bio","note":null,"profile_url":"/industries/industrial-bio"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:29:16.025Z","updated_at":"2026-09-03T07:29:16.025Z"}},{"listing_type":"company","name":"Modulari-T","slug":"modulari-t","tagline":"We teach your immune system to attack and cure cancer","description":"Cell and gene therapy promises to one day cure any disease; Modulari-T’s Platform produces the tools to fulfill that promise.\n\nModulari-T has designed a new family of synthetic genes that can reprogram cells to better sense their environment and modify their behavior accordingly. This can be used to engineer immune cells to efficiently recognize and kill cancer cells or to create stem cells able to regenerate any tissue.\n\nModulari-T looks to expand its technology to reach every area of cell therapy and become the platform of reference for cell engineering.\n\nModulari-T is a Y Combinator company (Winter 2023). YC-listed status: Active.","url":"https://modularit.bio/","is_stealth":false,"normalized_domain":"modularit.bio","normalized_url_key":"modularit.bio","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/cdfde836f1d168c7ec0299ab6b4daf90d112f929.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/modulari-t","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://modularit.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://modularit.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Gene Therapy","Cell Therapy","Synthetic Biology","Biotech","Oncology"],"stage":null,"founded_year":null,"location":"Montreal, QC, Canada; San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:28:22.865Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2023","Gene Therapy","Cell Therapy","Synthetic Biology","Biotech","Oncology"],"one_liner_for_search":"Modulari-T — We teach your immune system to attack and cure cancer (Y Combinator Winter 2023)","canonical_facts":["Y Combinator batch: Winter 2023","YC company status: Active","Team size (per YC directory): 4","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Former names: Modulari-T Biosciences","Regions (per YC): Canada, United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:28:22.865Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"cell-therapy","name":"Cell Therapy","note":null,"profile_url":"/industries/cell-therapy"},{"kind":"industry","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/industries/gene-therapy"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:28:22.865Z","updated_at":"2026-09-03T07:28:22.865Z"}},{"listing_type":"company","name":"Birch Biosciences","slug":"birch-biosciences","tagline":"We recycle plastic using engineered enzymes","description":"Birch Biosciences engineers enzymes for plastic recycling using synthetic biology and machine learning.  Our enzymes function as high performance “molecular scissors” that efficiently break down plastic polymers into chemical building blocks that can be used to manufacture high quality recycled plastic products.   Today, plastic manufacturing  is unsustainable and a major driver of climate change.   Birch Biosciences is developing an economical end-to-end plastic recycling process that reduces carbon emissions by 70% and enables a circular plastic economy.\n\nBirch Biosciences is a Y Combinator company (Summer 2022). YC-listed status: Active.","url":"https://www.birchbiosciences.com/","is_stealth":false,"normalized_domain":"birchbiosciences.com","normalized_url_key":"birchbiosciences.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/6d5ede074951640a2e67e11927c78affb1e31b81.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/birch-biosciences","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.birchbiosciences.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.birchbiosciences.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Industrials","Climate","Machine Learning","Synthetic Biology","Biotech","ClimateTech"],"stage":null,"founded_year":null,"location":"Portland, OR, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:13:10.691Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2022","Machine Learning","Synthetic Biology","Biotech","Climate","ClimateTech"],"one_liner_for_search":"Birch Biosciences — We recycle plastic using engineered enzymes (Y Combinator Summer 2022)","canonical_facts":["Y Combinator batch: Summer 2022","YC company status: Active","Team size (per YC directory): 10","YC industry: Industrials","YC subindustry: Industrials / Climate","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:13:10.691Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"climate","name":"Climate","note":null,"profile_url":"/industries/climate"},{"kind":"industry","slug":"climatetech","name":"ClimateTech","note":null,"profile_url":"/industries/climatetech"},{"kind":"industry","slug":"industrials","name":"Industrials","note":null,"profile_url":"/industries/industrials"},{"kind":"industry","slug":"machine-learning","name":"Machine Learning","note":null,"profile_url":"/industries/machine-learning"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:13:10.691Z","updated_at":"2026-09-03T07:13:10.691Z"}},{"listing_type":"company","name":"Cisterna Biologics","slug":"cisterna-biologics","tagline":"High quality mRNA for therapeutic application","description":"Founded in 2022 and based in San Diego, California, Cisterna Biologics is a technology company. It aims to solve some of the challenges currently facing the biotech industry to develop mRNA-based therapeutics – quality, quantity, longevity and cost of mRNA. As mRNA technology matures, it becomes imperative that these issues are solved so we can fully explore mRNA's endless possibilities as a therapeutic.\n\nCisterna uses proprietary technologies to either remove a contaminant at its source or replace the source itself. For example, to remove double-stranded RNA (dsRNA), we use ribozymes - molecular scissors - to precisely cut the mRNA at its 3’ end. This assures not only 3’ homogeneity, but also eliminates dsRNA, which are primarily produced due to self-templated additions at the 3’ end. Utilizing a PCR-like system to amplify the DNA template in large quantities eliminates the requirement for plasmid enrichment in bacteria, the prime source of endotoxin contamination. These are just a few examples of Cisterna’s powerful technologies being used to achieve our goal of 10x higher quality mRNA for therapeutic application.\n\nCisterna Biologics is a Y Combinator company (Summer 2022). YC-listed status: Active.","url":"https://www.cisternabx.com/","is_stealth":false,"normalized_domain":"cisternabx.com","normalized_url_key":"cisternabx.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/fa3a5ab85434b41a7ce57fae09e3c4645bc55f02.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/cisterna-biologics","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.cisternabx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.cisternabx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Synthetic Biology","Biotech","Therapeutics"],"stage":null,"founded_year":null,"location":"San Diego, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:11:28.397Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2022","Synthetic Biology","Biotech","Therapeutics"],"one_liner_for_search":"Cisterna Biologics — High quality mRNA for therapeutic application (Y Combinator Summer 2022)","canonical_facts":["Y Combinator batch: Summer 2022","YC company status: Active","Team size (per YC directory): 2","YC industry: Healthcare","YC subindustry: Healthcare","Former names: Cisterna Biologics LLC, Cisterna Biologic","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:11:28.397Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:11:28.397Z","updated_at":"2026-09-03T07:11:28.397Z"}},{"listing_type":"company","name":"Eugit Therapeutics","slug":"eugit-therapeutics","tagline":"Enabling Tissue Targeting of Therapies","description":"Eugit Therapeutics targets the issue of non-specific drugs that cause toxicity and clinical trial failures, affecting millions with tissue-specific inflammatory diseases. TAGHOME delivers drugs with precision to diseased tissues using T cell receptors, enhancing safety and improving efficacy. Our initial focus is on the 3.1 million U.S. individuals with Inflammatory Bowel Disease, aiming to initiate clinical trials within two years.\n\nCofounded by George Church (Harvard) and funded by Y Combinator (S22).\n\nEugit Therapeutics is a Y Combinator company (Summer 2022). YC-listed status: Active.","url":"https://www.eugittx.com/","is_stealth":false,"normalized_domain":"eugittx.com","normalized_url_key":"eugittx.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/a88b74cc086730f852f068c605f2dcaa54b40a16.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/eugit-therapeutics","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.eugittx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.eugittx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Cell Therapy","Synthetic Biology","Oncology","Biotechnology"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA; South San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:11:22.895Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2022","Cell Therapy","Synthetic Biology","Therapeutics","Oncology","Biotechnology"],"one_liner_for_search":"Eugit Therapeutics — Enabling Tissue Targeting of Therapies (Y Combinator Summer 2022)","canonical_facts":["Y Combinator batch: Summer 2022","YC company status: Active","Team size (per YC directory): 2","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Former names: EUGIT Tx, EUGIT Therapeutics, Eugit, Eugit Therapeutics Inc","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:11:22.895Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"},{"kind":"industry","slug":"cell-therapy","name":"Cell Therapy","note":null,"profile_url":"/industries/cell-therapy"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:11:22.895Z","updated_at":"2026-09-03T07:11:22.895Z"}},{"listing_type":"company","name":"Invert","slug":"invert","tagline":"Data analytics software for biomanufacturing.","description":"We build software to manage, analyze, and optimize bioprocessing data. Our initial customers are bio-industrial companies, who produce various products in bioreactors.\n\nInvert is a Y Combinator company (Winter 2022). YC-listed status: Active.","url":"https://invertbio.com/","is_stealth":false,"normalized_domain":"invertbio.com","normalized_url_key":"invertbio.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/1e1a589d7f48cf8cc7fb3658ec8dea0855d526a0.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/invert","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://invertbio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://invertbio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Industrial Bio","Cellular Agriculture","Machine Learning","Synthetic Biology","Biotech"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA; Remote","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:02:10.953Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2022","Cellular Agriculture","Machine Learning","Synthetic Biology","Biotech"],"one_liner_for_search":"Invert — Data analytics software for biomanufacturing. (Y Combinator Winter 2022)","canonical_facts":["Y Combinator batch: Winter 2022","YC company status: Active","Team size (per YC directory): 25","YC industry: Healthcare","YC subindustry: Healthcare / Industrial Bio","Former names: Invert Bio","Regions (per YC): United States of America, America / Canada, Remote, Fully Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:02:10.953Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"cellular-agriculture","name":"Cellular Agriculture","note":null,"profile_url":"/industries/cellular-agriculture"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"industrial-bio","name":"Industrial Bio","note":null,"profile_url":"/industries/industrial-bio"},{"kind":"industry","slug":"machine-learning","name":"Machine Learning","note":null,"profile_url":"/industries/machine-learning"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:02:10.953Z","updated_at":"2026-09-03T07:02:10.953Z"}},{"listing_type":"company","name":"Sensible Biotechnologies","slug":"sensible-biotechnologies","tagline":"Unlocking the next generation of mRNA medicines","description":"The future of mRNA therapeutics is hampered by manufacturing challenges and unless solved, its exciting potential may never be realised. Sensible enables the next generation of mRNA medicines by turning living cells into factories producing abundant, highly stable and non-immunogenic mRNA in a scalable and cost-effective way.\n\nSensible Biotechnologies is a Y Combinator company (Summer 2021). YC-listed status: Active.","url":"https://www.sensible.bio/","is_stealth":false,"normalized_domain":"sensible.bio","normalized_url_key":"sensible.bio","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/45d14c57e3b4e2739c65c0bb84a511608548ffa2.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/sensible-biotechnologies","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.sensible.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.sensible.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Synthetic Biology","Biotech","Manufacturing","Biotechnology"],"stage":null,"founded_year":null,"location":"Oxford, England, United Kingdom","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:58:03.441Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2021","Synthetic Biology","Biotech","Manufacturing","Therapeutics","Biotechnology"],"one_liner_for_search":"Sensible Biotechnologies — Unlocking the next generation of mRNA medicines (Y Combinator Summer 2021)","canonical_facts":["Y Combinator batch: Summer 2021","YC company status: Active","Team size (per YC directory): 24","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Former names: Genbiotics","Regions (per YC): United Kingdom, Europe, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:58:03.441Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"manufacturing","name":"Manufacturing","note":null,"profile_url":"/industries/manufacturing"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:58:03.441Z","updated_at":"2026-09-03T06:58:03.441Z"}},{"listing_type":"company","name":"Humane Genomics","slug":"humane-genomics","tagline":"A platform to make artificial viruses as cancer therapeutics.","description":"Humane Genomics has developed a platform to engineer cancer killing viruses. We have taken a first principles approach to design and make oncolytic viral therapies. Using a highly lytic RNA virus engineered with \"2 factor authentication\" (using selective infection and selective replication) they have an on-target to off-target kill ratio > 1000. We are working on our first indication, pediatric liver cancer (hepatoblastoma), with our partners at Texas Children's Hospital, who are world leading experts. We have in vivo (mouse) data showing safety and currently developing efficacy data and are showing 50% reduction in tumor volume.\n\nHumane Genomics is a Y Combinator company (Summer 2021). YC-listed status: Active.","url":"https://humanegenomics.com/","is_stealth":false,"normalized_domain":"humanegenomics.com","normalized_url_key":"humanegenomics.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/47e90007a89a7dd904342a1da559cc31eb51d9a3.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/humane-genomics","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://humanegenomics.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://humanegenomics.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Hard Tech","Synthetic Biology"],"stage":null,"founded_year":null,"location":"New York City, NY, USA; New York, NY, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:57:03.388Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2021","Hard Tech","Synthetic Biology"],"one_liner_for_search":"Humane Genomics — A platform to make artificial viruses as cancer therapeutics. (Y Combinator Summer 2021)","canonical_facts":["Y Combinator batch: Summer 2021","YC company status: Active","Team size (per YC directory): 5","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:57:03.388Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"hard-tech","name":"Hard Tech","note":null,"profile_url":"/industries/hard-tech"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:57:03.388Z","updated_at":"2026-09-03T06:57:03.388Z"}},{"listing_type":"company","name":"Adaptyv","slug":"adaptyv","tagline":"We're building fully automated labs for protein engineering","description":"Proteins are the most advanced nanotechnology we know of. At Adaptyv, we’re building a fully automated protein foundry to allow you to synthesize and test any protein you design.\n\nAdaptyv is a Y Combinator company (Summer 2021). YC-listed status: Active.","url":"https://www.adaptyvbio.com/","is_stealth":false,"normalized_domain":"adaptyvbio.com","normalized_url_key":"adaptyvbio.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/eab524ee6260ddc6c4e8438dbfde1921ccf736f5.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/adaptyv","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.adaptyvbio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.adaptyvbio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Drug Discovery and Delivery","AI-powered Drug Discovery","Synthetic Biology"],"stage":null,"founded_year":null,"location":"Lausanne, VD, Switzerland","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:55:34.242Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2021","AI-powered Drug Discovery","Synthetic Biology"],"one_liner_for_search":"Adaptyv — We're building fully automated labs for protein engineering (Y Combinator Summer 2021)","canonical_facts":["Y Combinator batch: Summer 2021","YC company status: Active","Team size (per YC directory): 25","YC industry: Healthcare","YC subindustry: Healthcare / Drug Discovery and Delivery","Former names: Adaptyv Biosystems","Regions (per YC): Switzerland, Europe"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:55:34.242Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"ai-powered-drug-discovery","name":"AI-powered Drug Discovery","note":null,"profile_url":"/industries/ai-powered-drug-discovery"},{"kind":"industry","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/industries/drug-discovery-and-delivery"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:55:34.242Z","updated_at":"2026-09-03T06:55:34.242Z"}},{"listing_type":"company","name":"Epinoma","slug":"epinoma","tagline":"We engineer proteins that control the operating system of biology.","description":"We engineer proteins that control the operating system of biology.\n\nEpinoma is a Y Combinator company (Summer 2021). YC-listed status: Active.","url":"https://www.epinoma.com/","is_stealth":false,"normalized_domain":"epinoma.com","normalized_url_key":"epinoma.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/294fcfc406e637a4349c10bf905e02f36d177455.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/epinoma","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.epinoma.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.epinoma.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Synthetic Biology","Biotech"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:50:22.545Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2021","Synthetic Biology","Biotech"],"one_liner_for_search":"Epinoma — We engineer proteins that control the operating system of biology. (Y Combinator Summer 2021)","canonical_facts":["Y Combinator batch: Summer 2021","YC company status: Active","Team size (per YC directory): 8","YC industry: Healthcare","YC subindustry: Healthcare","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:50:22.545Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:50:22.545Z","updated_at":"2026-09-03T06:50:22.545Z"}},{"listing_type":"company","name":"inSoma Bio","slug":"insoma-bio","tagline":"Helping Plastic Surgeons Rebuild Fat","description":"Helping Plastic Surgeons Rebuild Fat\n\ninSoma Bio is a Y Combinator company (Summer 2020). YC-listed status: Active.","url":"https://insomabio.com/","is_stealth":false,"normalized_domain":"insomabio.com","normalized_url_key":"insomabio.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/de0455624bad1e94310441869f841535ce28c99b.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/insoma-bio","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://insomabio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://insomabio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Medical Devices","Synthetic Biology"],"stage":null,"founded_year":null,"location":"Durham, NC, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:36:31.373Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2020","Synthetic Biology","Medical Devices"],"one_liner_for_search":"inSoma Bio — Helping Plastic Surgeons Rebuild Fat (Y Combinator Summer 2020)","canonical_facts":["Y Combinator batch: Summer 2020","YC company status: Active","Team size (per YC directory): 4","YC industry: Healthcare","YC subindustry: Healthcare / Medical Devices","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:36:31.373Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"medical-devices","name":"Medical Devices","note":null,"profile_url":"/industries/medical-devices"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:36:31.373Z","updated_at":"2026-09-03T06:36:31.373Z"}},{"listing_type":"company","name":"Ansa Biotechnologies","slug":"ansa-biotechnologies","tagline":"Next-generation DNA synthesis using enzymes","description":"Ansa Biotechnologies is developing a new way to make DNA that will be faster, cleaner, and more accurate than existing methods. Currently, DNA is manufactured via a chemical method that has remained mostly unchanged for 35 years. Our enzyme-based approach promises to dramatically accelerate innovation in biological research and biotechnology, including therapeutics, diagnostics and biomanufacturing.\n\nAnsa Biotechnologies is a Y Combinator company (Winter 2020). YC-listed status: Active.","url":"http://ansabio.com/","is_stealth":false,"normalized_domain":"ansabio.com","normalized_url_key":"ansabio.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/2b2832322fabbb9e5f2c1715ec5ca0ffdcf53f34.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/ansa-biotechnologies","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"http://ansabio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"http://ansabio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Industrial Bio","Synthetic Biology","Biotech"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA; Emeryville, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:32:29.727Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2020","Synthetic Biology","Biotech"],"one_liner_for_search":"Ansa Biotechnologies — Next-generation DNA synthesis using enzymes (Y Combinator Winter 2020)","canonical_facts":["Y Combinator batch: Winter 2020","YC company status: Active","Team size (per YC directory): 72","YC industry: Healthcare","YC subindustry: Healthcare / Industrial Bio","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:32:29.727Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"industrial-bio","name":"Industrial Bio","note":null,"profile_url":"/industries/industrial-bio"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:32:29.727Z","updated_at":"2026-09-03T06:32:29.727Z"}},{"listing_type":"company","name":"Living Carbon","slug":"living-carbon","tagline":"maximizing biomass on low quality land","description":"transforming degraded land into high quality environmental assets using end to end operational expertise and precision breeding.\n\nLiving Carbon is a Y Combinator company (Winter 2020). YC-listed status: Active.","url":"https://www.livingcarbon.com/","is_stealth":false,"normalized_domain":"livingcarbon.com","normalized_url_key":"livingcarbon.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/15bec4a7b933065121458477f9bf67ed7382b11f.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/living-carbon","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.livingcarbon.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.livingcarbon.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Industrials","Climate","Synthetic Biology","Biotech","Agriculture"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:32:16.611Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2020","Synthetic Biology","Biotech","Climate","Agriculture"],"one_liner_for_search":"Living Carbon — maximizing biomass on low quality land (Y Combinator Winter 2020)","canonical_facts":["Y Combinator batch: Winter 2020","YC company status: Active","Team size (per YC directory): 40","YC industry: Industrials","YC subindustry: Industrials / Climate","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:32:16.611Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"agriculture","name":"Agriculture","note":null,"profile_url":"/industries/agriculture"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"climate","name":"Climate","note":null,"profile_url":"/industries/climate"},{"kind":"industry","slug":"industrials","name":"Industrials","note":null,"profile_url":"/industries/industrials"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:32:16.611Z","updated_at":"2026-09-03T06:32:16.611Z"}},{"listing_type":"company","name":"Abalone Bio","slug":"abalone-bio","tagline":"We create activating antibodies to treat diseases others can’t.","description":"Abalone Bio is tackling challenging undrugged targets underlying diseases affecting millions, focusing first cell-specific antibody drugs to treat obesity and metabolic disease without the GI side effects that cause 25% of GLP-1 drug patients to quit after 1 year. \n\n+ High throughput experimental measurement uniquely leverages AI/ML:  We’ve engineered cells to measure antibodies for pharmacological activity, not just structure or binding like others, 100 million at a time, 100X+ the throughput of others. With our large, proprietary activity datasets, we uniquely leverage ML to both unlock the discovery of rare hits and generate optimized hits for challenging targets, starting with G-protein coupled receptors (GPCRs)\n\n+ Proven success: We have developed antibody agonists (activators) for 2 out of the 8 G-protein coupled receptors ever drugged by biotech.\n\n+ Pharma traction: We’ve secured 3 partnerships with $3M in revenue and $125M in downstream value. \n\n+ Externally validated science: We’ve been awarded $7M in non-dilutive grant funding for platform and program development.\n\nAbalone Bio is a Y Combinator company (Winter 2020). YC-listed status: Active.","url":"https://www.abalonebio.com/","is_stealth":false,"normalized_domain":"abalonebio.com","normalized_url_key":"abalonebio.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/e9f1d41bc9bfabd8ecaa9963112dc25b23472f0a.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/abalone-bio","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.abalonebio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.abalonebio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Drug Discovery and Delivery","Machine Learning","Synthetic Biology","Therapeutics","Drug discovery"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:27:15.102Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2020","Machine Learning","Synthetic Biology","Therapeutics","Drug discovery"],"one_liner_for_search":"Abalone Bio — We create activating antibodies to treat diseases others can’t. (Y Combinator Winter 2020)","canonical_facts":["Y Combinator batch: Winter 2020","YC company status: Active","Team size (per YC directory): 14","YC industry: Healthcare","YC subindustry: Healthcare / Drug Discovery and Delivery","Former names: Abalone Bio, Inc","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:27:15.102Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"drug-discovery","name":"Drug discovery","note":null,"profile_url":"/industries/drug-discovery"},{"kind":"industry","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/industries/drug-discovery-and-delivery"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"machine-learning","name":"Machine Learning","note":null,"profile_url":"/industries/machine-learning"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:27:15.102Z","updated_at":"2026-09-03T06:27:15.102Z"}},{"listing_type":"company","name":"Genecis Bio","slug":"genecis-bio","tagline":"Makes guilt-free plastics from food waste","description":"Makes guilt-free plastics from food waste\n\nGenecis Bio is a Y Combinator company (Winter 2020). YC-listed status: Active.","url":"https://www.genecis.co/","is_stealth":false,"normalized_domain":"genecis.co","normalized_url_key":"genecis.co","parent_slug":null,"parent":null,"type_data":{},"logo":null,"links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/genecis-bio","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.genecis.co/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.genecis.co/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Industrials","Manufacturing and Robotics","Bioplastic","Synthetic Biology","Climate","ClimateTech"],"stage":null,"founded_year":null,"location":"Toronto, ON, Canada","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:23:28.140Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2020","Bioplastic","Synthetic Biology","Climate","ClimateTech"],"one_liner_for_search":"Genecis Bio — Makes guilt-free plastics from food waste (Y Combinator Winter 2020)","canonical_facts":["Y Combinator batch: Winter 2020","YC company status: Active","Team size (per YC directory): 30","YC industry: Industrials","YC subindustry: Industrials / Manufacturing and Robotics","Former names: Genecis Bioindustries Inc., Genecis Bioindustries","Regions (per YC): Canada, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:23:28.140Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"bioplastic","name":"Bioplastic","note":null,"profile_url":"/industries/bioplastic"},{"kind":"industry","slug":"climate","name":"Climate","note":null,"profile_url":"/industries/climate"},{"kind":"industry","slug":"climatetech","name":"ClimateTech","note":null,"profile_url":"/industries/climatetech"},{"kind":"industry","slug":"industrials","name":"Industrials","note":null,"profile_url":"/industries/industrials"},{"kind":"industry","slug":"manufacturing-and-robotics","name":"Manufacturing and Robotics","note":null,"profile_url":"/industries/manufacturing-and-robotics"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:23:28.140Z","updated_at":"2026-09-03T06:23:28.140Z"}},{"listing_type":"company","name":"ZBiotics","slug":"zbiotics","tagline":"ZBiotics makes genetically engineered probiotics.","description":"ZBiotics is a synthetic biology company founded in 2016 and headquartered in San Francisco, California. The company bioengineers probiotic bacteria for nutraceutical and other applications. They launched the world's first genetically engineered probiotic in 2019 – a probiotic that breaks down a toxic byproduct of alcohol. They are currently developing a pipeline of additional engineered probiotics for other consumer health applications.\n\nZBiotics is a Y Combinator company (Winter 2018). YC-listed status: Active.","url":"https://zbiotics.com/","is_stealth":false,"normalized_domain":"zbiotics.com","normalized_url_key":"zbiotics.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/ac92cff794f7ac885c165d746204eeb840916f70.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/zbiotics","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://zbiotics.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://zbiotics.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Consumer Health and Wellness","Synthetic Biology","Health & Wellness","Food & Beverage"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:14:07.614Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2018","Synthetic Biology","Health & Wellness","Food & Beverage"],"one_liner_for_search":"ZBiotics — ZBiotics makes genetically engineered probiotics. (Y Combinator Winter 2018)","canonical_facts":["Y Combinator batch: Winter 2018","YC company status: Active","Team size (per YC directory): 22","YC industry: Healthcare","YC subindustry: Healthcare / Consumer Health and Wellness","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:14:07.614Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"consumer-health-and-wellness","name":"Consumer Health and Wellness","note":null,"profile_url":"/industries/consumer-health-and-wellness"},{"kind":"industry","slug":"food-and-beverage","name":"Food & Beverage","note":null,"profile_url":"/industries/food-and-beverage"},{"kind":"industry","slug":"health-and-wellness","name":"Health & Wellness","note":null,"profile_url":"/industries/health-and-wellness"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:14:07.614Z","updated_at":"2026-09-03T06:14:07.614Z"}},{"listing_type":"company","name":"Synvivia","slug":"synvivia","tagline":"Synvivia applies chemical control over cell behavior","description":"Synvivia applies chemical control over cell behavior. This allows us to optimize biomanufacturing of high-value biopharmaceutical products.\n\nSynvivia is a Y Combinator company (Summer 2016). YC-listed status: Active.","url":"https://www.synvivia.com/","is_stealth":false,"normalized_domain":"synvivia.com","normalized_url_key":"synvivia.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/4447def03db194c618a13840346e31a2394d316e.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/synvivia","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.synvivia.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.synvivia.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Industrial Bio","Artificial Intelligence","Synthetic Biology","Biotech","Manufacturing","Drug discovery"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA; Berkeley, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:03:24.766Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2016","Artificial Intelligence","Synthetic Biology","Biotech","Manufacturing","Drug discovery"],"one_liner_for_search":"Synvivia — Synvivia applies chemical control over cell behavior (Y Combinator Summer 2016)","canonical_facts":["Y Combinator batch: Summer 2016","YC company status: Active","Team size (per YC directory): 4","YC industry: Healthcare","YC subindustry: Healthcare / Industrial Bio","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:03:24.766Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"artificial-intelligence","name":"Artificial Intelligence","note":null,"profile_url":"/industries/artificial-intelligence"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"drug-discovery","name":"Drug discovery","note":null,"profile_url":"/industries/drug-discovery"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"industrial-bio","name":"Industrial Bio","note":null,"profile_url":"/industries/industrial-bio"},{"kind":"industry","slug":"manufacturing","name":"Manufacturing","note":null,"profile_url":"/industries/manufacturing"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:03:24.766Z","updated_at":"2026-09-03T06:03:24.766Z"}},{"listing_type":"company","name":"Opentrons","slug":"opentrons","tagline":"We make robots for biologists.","description":"Today, biologists spend too much time pipetting by hand. We think biologists should have robots to do pipetting for them. People doing science should be free of tedious benchwork and repetitive stress injuries. They should be able to spend their time designing experiments and analyzing data.\n\nThat's why we started Opentrons.\n\nWe make robots for biologists. Our mission is to provide the scientific community with a common platform to easily share protocols and reproduce each other's results. Our robots automate experiments that would otherwise be done by hand, allowing our community to spend more time pursuing answers to some of the 21st century’s most important questions.\n\nOpentrons is a Y Combinator company (Winter 2016). YC-listed status: Active.","url":"https://opentrons.com/","is_stealth":false,"normalized_domain":"opentrons.com","normalized_url_key":"opentrons.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/218a1e71ef58cf5c6cbd797a5c9a25f5b4525037.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/opentrons","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://opentrons.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://opentrons.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Diagnostics","Robotics","Synthetic Biology","Biotech"],"stage":null,"founded_year":null,"location":"New York City, NY, USA; New York, NY, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:00:13.937Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2016","Robotics","Synthetic Biology","Biotech"],"one_liner_for_search":"Opentrons — We make robots for biologists. (Y Combinator Winter 2016)","canonical_facts":["Y Combinator batch: Winter 2016","YC company status: Active","Team size (per YC directory): 300","YC industry: Healthcare","YC subindustry: Healthcare / Diagnostics","Former names: OpenTrons","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:00:13.937Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"diagnostics","name":"Diagnostics","note":null,"profile_url":"/industries/diagnostics"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"robotics","name":"Robotics","note":null,"profile_url":"/industries/robotics"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:00:13.937Z","updated_at":"2026-09-03T06:00:13.937Z"}},{"listing_type":"accelerator","name":"Nucleate Activator","slug":"nucleate-activator","tagline":"A free, equity-free six-month global accelerator for academic biotech founders that has supported 400+ life science ventures raising $420 million in venture…","description":"Nucleate Activator is a nonprofit-run, six-month equity-free program for academic scientists and early professionals launching biotech ventures, with chapters in 40+ regions and 200+ academic institutions worldwide. The program provides mutual-matching team formation, mentorship from biotech executives and investors, legal strategy, clinical consulting, and pitch showcases before expert judges. In 2025, the program selected 197 teams from 2,000+ applications across therapeutics, synthetic biology, diagnostics, and climate tech. Sponsors include Alnylam, Eli Lilly, Genentech, and MilliporeSigma.\n\nProgram duration: 6 months.","url":"https://nucleate.org/activator/","is_stealth":false,"normalized_domain":"nucleate.org","normalized_url_key":"nucleate.org","parent_slug":null,"parent":null,"type_data":{"application_url":"https://nucleate.org/activator/","application_status":"upcoming","formats":["Hybrid"],"focus_areas":["Biotech","Life Sciences","Therapeutics","Synthetic Biology","Diagnostics"],"equity_terms":"equity-free, no program fees","cohort_frequency":"annual","portfolio_url":"https://nucleate.org/portfolio/"},"logo":null,"links":[{"label":"Apply","url":"https://nucleate.org/activator/","platform":"apply"}],"entry_points":[{"kind":"homepage","url":"https://nucleate.org/activator/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},{"kind":"portfolio","url":"https://nucleate.org/portfolio/","audience":"any","primary":false,"listed_by":"community","derived_from":"type_data.portfolio_url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://nucleate.org/activator/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Accelerator","Biotech","Life Sciences","Academic","Non-profit","Therapeutics","Synthetic Biology","Diagnostics"],"stage":null,"founded_year":null,"location":"Multiple (Boston, Bay Area, New York, and 40+ global regions)","pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/nucleateactivator/","contact_email":null,"added_at":"2026-09-04T03:51:02.979Z","added_via":"web","geo":{"keywords":["Accelerator","Startup accelerator","Biotech","Life Sciences","Therapeutics","Synthetic Biology","Diagnostics"],"canonical_facts":["Run by Nucleate","Program duration: 6 months","Equity terms: equity-free, no program fees","Cohorts: annual"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-04T03:51:02.979Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"academic","name":"Academic","note":null,"profile_url":"/industries/academic"},{"kind":"industry","slug":"accelerator","name":"Accelerator","note":null,"profile_url":"/industries/accelerator"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"diagnostics","name":"Diagnostics","note":null,"profile_url":"/industries/diagnostics"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"},{"kind":"industry","slug":"non-profit","name":"Non-Profit","note":null,"profile_url":"/industries/non-profit"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-04T03:51:02.979Z","updated_at":"2026-09-04T03:51:02.979Z"}},{"listing_type":"accelerator","name":"IndieBio (SOSV)","slug":"indiebio-sosv","tagline":"The world's leading early-stage biotech and life science accelerator providing pre-seed investment and on-site laboratory access to scientists launching…","description":"IndieBio is SOSV's life science and deep tech accelerator with locations in San Francisco and New York City, offering pre-seed investment and on-site bio-lab access to biotech, synthetic biology, and life science founders since 2015. The program runs multiple cohorts per year in each city, culminating in demo days that attract top life sciences investors. In early 2026, IndieBio rebranded to SOSV SF and SOSV NY to reflect a broader deep tech scope encompassing biology, chemistry, physics, and AI.","url":"https://indiebio.co/","is_stealth":false,"normalized_domain":"indiebio.co","normalized_url_key":"indiebio.co","parent_slug":null,"parent":null,"type_data":{"application_url":"https://sosv.com/apply/","application_status":"rolling","formats":["In person"],"focus_areas":["Biotech","Life Sciences","Synthetic Biology","Diagnostics","Deep Tech"],"funding_offer":"Pre-seed investment (amount varies per company)","cohort_frequency":"multiple cohorts per year","portfolio_url":"https://sosv.com/portfolio/"},"logo":null,"links":[{"label":"Apply","url":"https://sosv.com/apply/","platform":"apply"}],"entry_points":[{"kind":"homepage","url":"https://indiebio.co/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},{"kind":"apply","url":"https://sosv.com/apply/","audience":"human","primary":false,"listed_by":"community","derived_from":"type_data.application_url","on_listing_domain":false},{"kind":"portfolio","url":"https://sosv.com/portfolio/","audience":"any","primary":false,"listed_by":"community","derived_from":"type_data.portfolio_url","on_listing_domain":false}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://indiebio.co/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Accelerator","Biotech","Life Sciences","Deep Tech","Synthetic Biology","Diagnostics"],"stage":null,"founded_year":2015,"location":"San Francisco, USA","pricing":null,"twitter":"https://x.com/indiebio","github":null,"linkedin":"https://www.linkedin.com/company/indiebio/","contact_email":null,"added_at":"2026-09-04T03:50:13.532Z","added_via":"web","geo":{"keywords":["Accelerator","Startup accelerator","Biotech","Life Sciences","Synthetic Biology","Diagnostics","Deep Tech"],"canonical_facts":["Run by SOSV","Funding offer: Pre-seed investment (amount varies per company)","Cohorts: multiple cohorts per year"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-04T03:50:13.532Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"accelerator","name":"Accelerator","note":null,"profile_url":"/industries/accelerator"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"deep-tech","name":"Deep Tech","note":null,"profile_url":"/industries/deep-tech"},{"kind":"industry","slug":"diagnostics","name":"Diagnostics","note":null,"profile_url":"/industries/diagnostics"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-04T03:50:13.532Z","updated_at":"2026-09-04T03:50:13.532Z"}},{"listing_type":"accelerator","name":"Cicada Innovations","slug":"cicada-innovations","tagline":"Australia's leading deep tech incubator and accelerator with a 25-year track record developing science and engineering ventures in Sydney.","description":"Cicada Innovations is a Sydney-based deep tech incubator and accelerator founded in 2000. It supports startups and scaleups working on cutting-edge science including advanced materials, synthetic biology, and AI applied to healthcare, food security, and climate challenges. Resident companies access specialized labs, mentors, and long-term commercialization support. Cicada also operates Cicada MedLab, a dedicated 4-month medtech accelerator providing A$50,000 investment.\n\nProgram duration: 4 months (MedLab).","url":"https://www.cicadainnovations.com/","is_stealth":false,"normalized_domain":"cicadainnovations.com","normalized_url_key":"cicadainnovations.com","parent_slug":null,"parent":null,"type_data":{"application_url":"https://www.cicadainnovations.com/apply","application_status":"rolling","formats":["In person"],"focus_areas":["Deep Tech","Advanced Materials","Synthetic Biology","AI","MedTech","Climate Tech"],"funding_offer":"A$50,000 (MedLab accelerator track)"},"logo":null,"links":[{"label":"Apply","url":"https://www.cicadainnovations.com/apply","platform":"apply"}],"entry_points":[{"kind":"homepage","url":"https://www.cicadainnovations.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},{"kind":"apply","url":"https://www.cicadainnovations.com/apply","audience":"human","primary":false,"listed_by":"community","derived_from":"type_data.application_url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.cicadainnovations.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Accelerator","Incubator","Australia","Deep Tech","MedTech","Climate Tech","Advanced Materials","Synthetic Biology"],"stage":null,"founded_year":2000,"location":"Sydney, Australia","pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/cicadainnovations","contact_email":null,"added_at":"2026-09-04T03:49:39.174Z","added_via":"web","geo":{"keywords":["Accelerator","Startup accelerator","Deep Tech","Advanced Materials","Synthetic Biology","AI","MedTech","Climate Tech"],"canonical_facts":["Program duration: 4 months (MedLab)","Funding offer: A$50,000 (MedLab accelerator track)"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-04T03:49:39.174Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"accelerator","name":"Accelerator","note":null,"profile_url":"/industries/accelerator"},{"kind":"industry","slug":"advanced-materials","name":"Advanced Materials","note":null,"profile_url":"/industries/advanced-materials"},{"kind":"industry","slug":"australia","name":"Australia","note":null,"profile_url":"/industries/australia"},{"kind":"industry","slug":"climate-tech","name":"Climate Tech","note":null,"profile_url":"/industries/climate-tech"},{"kind":"industry","slug":"deep-tech","name":"Deep Tech","note":null,"profile_url":"/industries/deep-tech"},{"kind":"industry","slug":"incubator","name":"Incubator","note":null,"profile_url":"/industries/incubator"},{"kind":"industry","slug":"medtech","name":"MedTech","note":null,"profile_url":"/industries/medtech"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-04T03:49:39.174Z","updated_at":"2026-09-04T03:49:39.174Z"}}],"total":32,"limit":50,"offset":0}